DOCETAXEL INJECTION USP DIN 02361957
Health Canada record
| Active ingredient(s) | DOCETAXEL 10 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01CD02 DOCETAXEL |
| Original market date | 01-Mar-2011 |
| Current status date | 16-Jun-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DOCETAXEL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02439336 | DOCETAXEL INJECTION | SANDOZ CANADA INCORPORATED | Solution | DOCETAXEL 10 MG | Marketed |
| 02458020 | DOCETAXEL INJECTION | BIOLYSE PHARMA CORPORATION | Solution | DOCETAXEL 20 MG | Marketed |
| 02444410 | ACT DOCETAXEL 40 MG/ML | ACTAVIS PHARMA COMPANY | Solution | DOCETAXEL 20 MG | Cancelled Pre Market |
| 02441845 | ACT DOCETAXEL 40 MG/ML | ACTAVIS PHARMA COMPANY | Solution | DOCETAXEL 80 MG | Cancelled Pre Market |
| 02437031 | DOCETAXEL INJECTION | ACCORD HEALTHCARE INC | Solution | DOCETAXEL 20 MG | Dormant |
| 02412225 | DOCETAXEL INJECTION | TEVA CANADA LIMITED | Solution | DOCETAXEL 20 MG | Cancelled Post Market |
| 02412233 | DOCETAXEL INJECTION | TEVA CANADA LIMITED | Solution | DOCETAXEL 80 MG | Cancelled Post Market |
| 02436361 | PMS-DOCETAXEL | PHARMASCIENCE INC | Kit; Solution | DOCETAXEL 20 MG | Cancelled Pre Market |
| 02436388 | PMS-DOCETAXEL | PHARMASCIENCE INC | Kit; Solution | DOCETAXEL 80 MG | Cancelled Pre Market |
| 02465655 | TARO-DOCETAXEL | TARO PHARMACEUTICALS INC | Solution | DOCETAXEL 160 MG | Cancelled Pre Market |
| 02465531 | TARO-DOCETAXEL | TARO PHARMACEUTICALS INC | Solution | DOCETAXEL 20 MG | Cancelled Pre Market |
| 02465647 | TARO-DOCETAXEL | TARO PHARMACEUTICALS INC | Solution | DOCETAXEL 80 MG | Cancelled Pre Market |
| 02177099 | TAXOTERE | SANOFI-AVENTIS CANADA INC | Solution | DOCETAXEL 20 MG | Cancelled Post Market |
| 02177080 | TAXOTERE | SANOFI-AVENTIS CANADA INC | Solution | DOCETAXEL 80 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 19421 | 2017-06-16 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 12104 | 2011-02-25 | New Drug Submission (NDS) |
International API supply for DOCETAXEL
13 valid EDQM Certificates of Suitability from 13 holders. 24 active FDA Drug Master Files.
Request a quote for DOCETAXEL INJECTION USP